Domínguez-Baleón, Carmen
Ong, Jue-Sheng
Scherzer, Clemens R.
Rentería, Miguel E.
Dong, Xianjun
Funding for this research was provided by:
Parkinson's Foundation (PF-APDA-SFW-1913)
American Parkinson Disease Association
National Institutes of Health (U01NS082157, U01NS095736, U01NS100603)
National Health and Medical Research Council (GNT1002821)
Article History
Received: 6 November 2020
Accepted: 8 June 2021
First Online: 7 July 2021
Competing interests
: CRS has collaborated with Pfizer, Opko, Proteome Sciences, Genzyme Inc; has consulted for Genzyme; has served as Advisor to the Michael J. Fox Foundation, NIH, Department of Defense; is on the Scientific Advisory Board of the American Parkinson Disease Association; has received funding from the NIH, the U.S. Department of Defense, the Harvard NeuroDiscovery Center, the Michael J. Fox Foundation, and American Parkinson Disease Association. XD has received funding from the NIH, the Michael J. Fox Foundation, and American Parkinson Disease Association. The other authors declare no competing interests.